
ProFoundâ„¢ Therapeutics
ProFoundâ„¢ Therapeutics is pioneering the discovery of a vastly expanded human proteome and using its newfound insights to unlock a universe of potential new medicines. The company’s ProFoundryâ„¢ Platform uses state-of-the-art protein detection technologies to systematically identify and validate proteins and dissect their therapeutic potential. The result is an ever-expanding database of tens of thousands of novel proteins, including their connectivity, functionality, and roles in health and disease. ProFound Therapeutics was founded in 2020 at Flagship Labs, a unit of »Æ¹ÏÊÓƵapp.
Latest News from ProFoundâ„¢ Therapeutics
- »Æ¹ÏÊÓƵapp and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer 06.12.2024
- »Æ¹ÏÊÓƵapp Appoints John Lepore as CEO-Partner and CEO of ProFound Therapeutics 10.02.2023
- »Æ¹ÏÊÓƵapp Unveils ProFoundâ„¢ Therapeutics to Illuminate an Expanded Universe of Human Proteins with the Potential to Enable a Multitude of New Medicines 05.26.2022